PubRank

Marie-Odile Krebs

Author PubWeight™ 76.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011 4.01
2 Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 2009 3.88
3 Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 2010 3.69
4 Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008 3.52
5 De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A 2010 3.13
6 Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011 1.94
7 De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet 2010 1.79
8 The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull 2007 1.38
9 De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry 2011 1.25
10 Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry 2010 1.17
11 Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull 2014 1.10
12 Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci 2007 1.10
13 Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005 1.05
14 Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res 2003 1.04
15 Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. Eur Arch Psychiatry Clin Neurosci 2009 1.01
16 Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res 2004 1.01
17 Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med 2005 0.98
18 Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 2004 0.94
19 Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) 2012 0.94
20 Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet 2007 0.89
21 The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord 2011 0.88
22 Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neuropsychopharmacol 2009 0.88
23 Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull 2012 0.87
24 Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol 2004 0.87
25 CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol 2011 0.87
26 Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry 2006 0.86
27 Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 2005 0.86
28 Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res 2004 0.86
29 Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain 2013 0.85
30 Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res 2005 0.85
31 Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2003 0.83
32 Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol 2009 0.82
33 Nicotine use in schizophrenia and disinhibition. Psychiatry Res 2004 0.82
34 Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol 2009 0.82
35 Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One 2010 0.82
36 Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res 2009 0.82
37 Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res 2010 0.82
38 Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord 2011 0.82
39 Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord 2008 0.81
40 Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet 2006 0.81
41 The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord 2010 0.81
42 Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet 2008 0.81
43 De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry 2010 0.81
44 Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia 2010 0.81
45 Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil 2014 0.80
46 Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol 2011 0.80
47 Exploring and visualizing multidimensional data in translational research platforms. Brief Bioinform 2016 0.79
48 Don't be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory. Front Behav Neurosci 2013 0.79
49 Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol 2010 0.79
50 Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res 2002 0.79
51 Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res 2010 0.79
52 A step toward an objective quantification of subtle neurological signs in schizophrenia. Psychiatry Res 2012 0.78
53 Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr Res 2007 0.78
54 Correlates between neurological soft signs and saccadic parameters in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009 0.78
55 Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores. Psychiatry Res 2012 0.78
56 Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement. J Clin Exp Neuropsychol 2009 0.78
57 Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci 2011 0.78
58 Cannabis use and schizophrenia. Am J Psychiatry 2005 0.78
59 Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia. Front Psychiatry 2010 0.77
60 Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav Brain Funct 2013 0.77
61 Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) 2007 0.77
62 Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights. World J Biol Psychiatry 2011 0.77
63 Episodic memory and impairment of an early encoding process in schizophrenia. Neuropsychology 2010 0.77
64 Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis. Eur Addict Res 2011 0.77
65 Variable individual sensitivity to cannabis in patients with schizophrenia. Int J Neuropsychopharmacol 2010 0.77
66 Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients. World J Biol Psychiatry 2011 0.76
67 Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2003 0.76
68 Hyperfrontality and hypoconnectivity during refreshing in schizophrenia. Psychiatry Res 2012 0.76
69 Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients. J Psychiatry Neurosci 2008 0.76
70 Gender identity disorders and bipolar disorder associated with the ring Y chromosome. Am J Psychiatry 2007 0.76
71 Cerebellum development and schizophrenia: an association study of the human homeogene Engrailed 2. Psychiatry Res 2004 0.76
72 Neurological soft signs in non-psychotic patients with cannabis dependence. Addict Biol 2010 0.76
73 Postnatal effect of embryonic neurogenesis disturbance on reelin level in organotypic cultures of rat hippocampus. Brain Res 2006 0.75
74 [Cannabis-induced cognitive and psychiatric disorders]. Bull Acad Natl Med 2015 0.75
75 [Schizophrenic disorders: current etiologic and clinical knowledge]. Bull Acad Natl Med 2005 0.75
76 [From shock therapies to new neuromodulation techniques]. Soins Psychiatr 2013 0.75
77 [Adaptation of a soft-signs scale to children with autism spectrum disorders]. Tunis Med 2009 0.75
78 Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant. J Clin Psychopharmacol 2011 0.75
79 [Principles of cognitive remediation in schizophrenia]. Bull Acad Natl Med 2011 0.75
80 [Chromosomal integrity and schizophrenia]. Med Sci (Paris) 2009 0.75
81 [Early detection and early intervention in first episode psychosis]. Rev Prat 2013 0.75
82 Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia. Expert Opin Drug Discov 2009 0.75
83 Comparing effects of perceptual and reflective repetition on subjective experience during later recognition memory. Conscious Cogn 2007 0.75